The AHA Guidelines and Scientific Statements Handbook
eBook - ePub

The AHA Guidelines and Scientific Statements Handbook

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

The AHA Guidelines and Scientific Statements Handbook

About this book

Society-sanctioned guidelines on care are valuable tools, but accessing key information from the often complicated statements has been a daunting task. Now, practitioners and their institutions have a clear path to successful application of guidelines from the American Heart Association. This book outlines the key AHA guidelines, Statements, and Performance Measures and includes comparisons with the associated European guidelines. This book also has a strong online component, which will alert users who sign up to new updates to the guidelines and other relevant information. It will also have links through to the full guidelines and statements.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access The AHA Guidelines and Scientific Statements Handbook by Valentin Fuster in PDF and/or ePUB format, as well as other popular books in Medicine & Cardiology. We have over one million books available in our catalogue for you to explore.

Information

Year
2011
Print ISBN
9781405184632
eBook ISBN
9781444359749
Edition
1
Subtopic
Cardiology
1 CHRONIC STABLE ANGINA
Theodore D. Fraker, Stephan D. Fihn, and Raymond J. Gibbons
Introduction
Classification of angina pectoris
Demographics of angina pectoris
Patients with new onset or changing anginal symptoms
The development of practice guidelines
Asymptomatic individuals
Recommendations for the management of patients with chronic stable angina
Diagnosis
A. History and physical examination
B. Associated conditions
C. Noninvasive testing
D. Invasive testing: value of coronary angiography
Risk stratification
A. Clinical evaluation
B. Noninvasive testing
C. Use of exercise test results in patient management
D. Coronary angiography and left ventriculography
Treatment
A. Pharmacologic therapy
Coronary disease risk factors and evidence that treatment can reduce the risk for coronary disease events
Patient follow-up: monitoring of symptoms and anti-anginal therapy
Future issues
Special consideration for women
New information on percutaneous revascularization to be considered for the next chronic stable angina guideline
New therapeutic agents to be considered for the next chronic stable angina guideline
Introduction
Angina pectoris is a clinical syndrome characterized by discomfort in the chest, jaw, back or arm typically aggravated by exertion or emotional stress and relieved by rest or nitroglycerin. Angina pectoris is usually associated with epicardial coronary artery disease including one or more obstructions of greater than 70%, but it can also occur in patients with valvular heart disease, hypertrophic cardiomyopathy, or uncontrolled hypertension. Symptoms are thought to result from regional or global myocardial ischemia due to mismatch between myocardial oxygen supply and demand (Table 1.1). In women, angina pectoris can be seen in the absence of obvious epicardial coronary artery obstruction or other cardiac pathology, presumably due to coronary artery endothelial dysfunction or other factors. Chronic stable angina refers to anginal symptoms that occur daily, weekly or less frequently and are typically predictable and reproducible [1–4].
Table 1.1 Conditions provoking or exacerbating ischemia
Increased oxygen demand Decreased oxygen supply
Noncardiac Noncardiac
Hyperthermia Anemia
Hyperthyroidism Hypoxemia
Sympathomimetic toxicity (e.g., cocaine use) Pneumonia
Hypertension Asthma
Anxiety Chronic obstructive pulmonary disease
Arteriovenous fistulae Pulmonary hypertension
Interstitial pulmonary fibrosis
Cardiac Obstructive sleep apnea
Hypertrophic cardiomyopathy Sickle cell disease
Aortic stenosis Sympathomimetic toxicity (e.g., cocaine use)
Dilated cardiomyopathy Hyperviscosity
Tachycardia Polycythemia
Ventricular Leukemia
Supraventricular Thrombocytosis
Hypergammaglobulinemia
Cardiac
Aortic stenosis
Hypertrophic cardiomyopathy
Classification of angina pectoris
Chest discomfort can be described as typical angina, atypical angina or non-anginal chest pain, depending upon whether or not symptoms occur with increased myocardial oxygen demand and are relieved by rest or nitroglycerin. Typical angina is usually described as a sensation of chest tightness, heaviness, pressure, burning or squeezing sometimes accompanied by radiation to the inner arm, jaw, back or epigastrium. What makes the discomfort “typical” is the predictable relationship to increased activity (implying increased myocardial oxygen consumption) and subsequent relief with rest or NTG (Table 1.2).
Table 1.2 Clinical classification of chest pain
Typical angina (definite)
(1) Substernal chest discomfort with a characteristic quality and duration that is (2) provoked by exertion or emotional stress and (3) relieved by rest or NTG.
Atypical angina (probable)
Meets two of the above characteristics.
Noncardiac chest pain
Meets one or none of the typical anginal characteristics.
Modified from Diamond, IACC, 1983.
The severity of angina pectoris is customarily described using the Canadian Cardiovascular Society Classification System (Table 1.3).
Table 1.3 Grading of angina pectoris by the Canadian Cardiovascular Society Classification System
Class I
Ordinary physical activity does not cause angina, such as walking, climbing stairs. Angina (occurs) with strenuous, rapid or prolonged exertion at work or recreation.
Class II
Slight limitation of ordinary activity. Angina occurs on walking or climbing stairs rapidly, walking uphill, walking or stair climbing after meals, or in cold, or in wind, or under emotional stress, or only during the few hours after awakening. Angina occurs on walking more than 2 blocks on the level and climbing more than one flight of ordinary stairs at a normal pace and in normal condition.
Class III
Marked limitations of ordinary physical activity. Angina occurs on walking one to two blocks on the level and climbing one flight of stairs in normal conditions at a normal pace.
Class IV
Inability to carry on any physical activity without discomfort – anginal symptoms may be present at rest.
Source: Campeau L. Grading of angina pectoris [letter]. Circulation, 1976;54:522–523. Copyright © 1976. American Heart Association. Inc. Reprinted with permission.
Demographics of angina pectoris
Coronary artery disease, the principal cause of angina pectoris, is thought to be present in 13,200,000 American adults, about half of whom (6,500,000 or 3.8% of the population) have angina pectoris or chest pain [4]. The incidence of stable angina is about 400,000 persons per year and there are an estimated 63,000 hospital discharges per year (2003) [4]. The annual mortality rate is hard to assess in the US since angina pectoris is rarely listed on death certificates as the cause of death. Data from the European Society of Cardiology estimates the annual mortality rate ranges from 0.9–1.4% and the annual incidence of non-fatal MI ranges from 0.5–2.6% [3]. Only about 20% of cardiac events are preceded by long-standing angina [4].
Patients with new onset or changing anginal symptoms
Patients who present with a history of angina that has recently started or has changed in frequency, severity or pattern are often classified as having unstable angina. These patients can be subdivided by their short-term risk of death (Table 1.4). Patients at high or moderate risk often have an acute coronary syndrome caused by coronary artery plaques that have ruptured. Their risk of death is intermediate, between that of patients with acute MI and patients with stable angina. The initial evaluation of high- or moderate-risk patients with unstable angina is best carried out in the inpatient setting. However, low-risk patients with unstable angina have a short-term risk similar to that of patients with stable angina. Their evaluation can be accomplished safely and expeditiously in an outpatient setting. The recommendations made in these guidelines do not apply to patients with high- or moderate-risk unstable angina but are applicable to the low-risk unstable angina group.
Table 1.4 Short-term risk of death or nonfatal myocardial infarction in patients with unstable angina
High risk Intermediate risk Low risk
At least one of the following features must be present: No high-risk features but must have any of the following: No high- or intermediate-risk feature but may have any of the following:
Prolonged ongoing (>20 min) rest pain Prolonged (>20 min) rest angina, now resolved, with moderate or high likelihood of CAD Increased angina frequency, severity, or duration
Pulmonary edema, most likely related to ischemia Rest angina (>20 min or relieved with sublingual nitroglycerin) Angina provoked at a lower threshold
Angina at rest with dynamic ST changes ≥1 mm Nocturnal angina New onset angina with onset 2 weeks to 2 months prior to presentation
Angina with new or worsening MR murmur Angina with dynamic T-ware changes Normal or unchanged ECG
Angina with S3 or new/worsening rales New onset CCSC III or IV angina in the past 2 weeks with moderate or high likelihood of CAD
Angina with hypotension Pathologic Q waves or resting ST depression ≤1 mm in multiple lead groups (anterior, inferior, lateral)
Age >65 years
CCSC indicates Canadian Cardiovascular Society Classification.
Note: Estimation of the short-term risks of death and nonfatal MI in unstable angina is a complex multivariable problem that cannot be fully specified in a table such as this. Therefore, the table is meant to offer general guidance and illustration rather than rigid algorithms.
The development of practice guidelines
The American College of Cardiology/American Heart Association Task Force on Practice Guidelines met in 2001 and 2002 to update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina. This guideline was published in 2003. In 2007, a subgroup of the writing committee updated the 2002 Chronic Stable Guideline to be consistent with the AHA/ACC Guidelines for Secondary Prevention for Patients with Coronary and Other Atherosclerotic Vascular Disease. In 2006, the European Society of Cardiology [3] published its own guideline which differs somewhat from the ACC/AHA guideline. Both sets of guidelines will be considered in this chapter.
The Classification of Recommendations (COR) and Level of Evidence (LOE) are expressed in the ACC/AHA/ESC format (see table in front of book). These recommendations are evidence-based from published data where applicable.
Asymptomatic individuals
This chapter and the recommendations that follow are intended to apply to symptomatic patients. These were the focus of the original 1999 guideline. The 2002 update included additional sections and recommendations for asymptomatic patients with known or suspected coronary artery disease (CAD). Such individuals are often identified on the basis of evidence of a previous myocardial infarction by history and/or electrocardiographic changes, coronary angiography, or an abnormal noninvasive test, including coronary calcification on computed tomography (CT). Multiple ACC/AHA guidelines, scientific statements and expert consensus documents have discouraged the use of noninvasive tests, including ambulatory monitoring, treadmill testing, stress echocardiography, stress myocardial perfusion, and CT, in asymptomatic individuals. Their inclusion in the 2002 guideline did not represent an endorsement of such tests for the purposes of screening, but rather an acknowledgment of the clinical reality that asymptomatic patients may present for ...

Table of contents

  1. Cover
  2. Title
  3. Copyright
  4. List of Contributors
  5. Preface
  6. 1 CHRONIC STABLE ANGINA
  7. 2 UNSTABLE ANGINA/NON-ST-ELEVATION MYOCARDIAL INFARCTION
  8. 3 ST-ELEVATION MYOCARDIAL INFARCTION
  9. 4 CARDIAC REHABILITATION AND SECONDARY PREVENTION PROGRAMS
  10. 5 SECONDARY PREVENTION FOR PATIENTS WITH CORONARY AND OTHER ATHEROSCLEROTIC VASCULAR DISEASE
  11. 6 PERCUTANEOUS CORONARY INTERVENTION
  12. 7 CORONARY ARTERY BYPASS GRAFT SURGERY
  13. 8 PERIOPERATIVE CARDIOVASCULAR EVALUATION AND CARE FOR NONCARDIAC SURGERY
  14. 9 LOWER EXTREMITY PERIPHERAL ARTERY DISEASE
  15. 10 CHOLESTEROL MANAGEMENT IN THE CONTEXT OF RISK FACTOR PROFILE
  16. 11 HYPERTENSION
  17. 12 CARDIOVASCULAR DISEASE PREVENTION IN WOMEN
  18. 13 HEART FAILURE
  19. 14 CARDIOMYOPATHIES
  20. 15 ATRIAL FIBRILLATION
  21. 16 SUPRAVENTRICULAR ARRHYTHMIAS
  22. 17 VENTRICULAR ARRHYTHMIAS AND SUDDEN CARDIAC DEATH
  23. 18 VALVULAR HEART DISEASE
  24. 19 INFECTIVE ENDOCARDITIS
  25. 20 CARDIAC CT IMAGING
  26. APPENDIX UPDATE ON CORONARY ARTERY BYPASS SURGERY: CURRENT AND FUTURE TRENDS
  27. OTHER STATEMENTS PUBLISHED IN 2008
  28. Index
  29. COI Table